Never Run Out Of Buyers To Sell To.
We, at Bioneb, have over the past five years developed leading ultrasonic vibrating platinum mesh technology for the nebulization and delivery of drugs in the most efficient and cost-effective manner. This is through the pulmonary tract, which is the most efficient way to deliver drugs. Our technology produces nanoparticles of medication that are less than five microns in size, critical for successful pulmonary delivery. Human testing of many FDA approved drugs is ongoing. Many companies and universities are racing against time to develop a successful vaccine for Covid-19. Unfortunately, a…
Annual Revenue$10M to $25M
Estimated OwnershipBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.